Suchergebnisse - "Bousquet, Justine"

PubPharm (6)

1

Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Zalacain, M. | Achard, P. | Llanos, A. | +13

2

Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients

enthalten in: Scientific reports | 2023

von Llanos, A. | Achard, P. | Bousquet, J. | +8

3

Discovery of ANT3310, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumannii

enthalten in: Journal of medicinal chemistry | 2020

von Davies, D. | Leiris, S. | Zalacain, M. | +25

4

Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Das, S. | Johnson, A. | McEntee, L. | +11

CommentIn: Antimicrob Agents Chemother. 2021 Jan 20;65(2):. - PMID 33229430

5

ANT2681 : SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae

enthalten in: ACS infectious diseases | 2020

von Davies, D. | Leiris, S. | Sprynski, N. | +27

6

SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model

enthalten in: ACS infectious diseases | 2019

von Leiris, S. | Coelho, A. | Castandet, J. | +27

1
[1]